Igrose Star Cream is a topical formulation combining Ciprofloxacin (1% w/w), Metronidazole (1% w/w), Terbinafine (1% w/w), and Clobetasol (0.05% w/w), designed for the management of mixed bacterial, protozoal, fungal infections, and inflammatory dermatoses. Ciprofloxacin, a broad-spectrum fluoroquinolone antibiotic, targets susceptible Gram-positive and Gram-negative bacteria by inhibiting DNA gyrase and topoisomerase IV, thereby preventing bacterial replication. Metronidazole exhibits potent antiprotozoal and antibacterial activity against anaerobic organisms by disrupting DNA synthesis. Terbinafine, an allylamine antifungal agent, inhibits squalene epoxidase, leading to ergosterol depletion and fungal cell membrane disruption, effective against dermatophytes and other fungi. Clobetasol propionate, a super potent corticosteroid, provides anti-inflammatory, immunosuppressive, and antipruritic effects, reducing erythema, edema, and itching associated with inflammatory skin conditions. The synergistic combination in Igrose Star Cream is indicated for complicated cutaneous infections with mixed microbial etiology accompanied by significant inflammation, such as infected eczema, dermatitis, and fungal-bacterial co-infections. Application should follow medical advice, typically applied twice daily to affected areas, avoiding prolonged use due to potential corticosteroid-related adverse effects. Caution is advised in patients with hypersensitivity to any component, and use on extensive areas or occluded skin should be monitored to prevent systemic absorption.